Ancillary Products for Cell and Gene Therapy and Tissue Engineering: USP Initiative

by Roger Dabbah, PhD
Volume 3, Issue 4 (July/August 2004)

The United States Pharmacopeia (USP) is a 184-year-old organization that has been in the forefront of technology since its inception. From publishing a manual about how to prepare therapeutic potions, USP has evolved into a compendium of standards and information on manufactured pharmaceutical products, with more than 4,000 monographs covering drug substances and biologics, and their dosage forms, excipients, and nutritional supplements. It is not surprising that the USP initiative in cell and gene therapy and tissue engineering has closely followed the emergence of these technologies...

Citation:
Dabbah R. Ancillary Products for Cell and Gene Therapy and Tissue Engineering: USP Initiative.
BioProcess J, 2004; 3(4): 21-22.